Cells4Life announces the UKs first NAP approved training course for umbilical cord blood procurement
Cells4Life, the private umbilical cord blood storage company based in Brighton, Sussex, has today announced the launch of its umbilical cord blood collection training course, available for healthcare professionals.
The course has been developed in conjunction with the National Association of Phlebotomists and will be running throughout the year at various locations within the UK.
The course has been designed specifically to train healthcare professionals in the collection of umbilical cord blood using the Cells4Life collection protocol.
Cells4Life was the first company to offer a private phlebotomy service and has always maintained that cord blood collection should only be performed by a trained professional. The Cells4Life collection process was developed in conjunction with RCOG guidelines and leading consultant obstetrician and gynaecologists. It recommends that the cord blood is collected after the 3rd stage of labour, following the cord being clamped and the placenta being delivered.
“At Cells4Life we feel that collecting the blood at this stage interferes less with the birthing process and this is a guideline adopted by the RCOG in their Position Paper 2. We are delighted by today’s announcement from the Human Tissue Authority that only trained professionals should perform this procedure – something we have always recommended. Cells4Life is once again setting the industry standards” said Rebecca Rutter, Operations Manager at Cells4Life.
Videos
Ειδήσεις’
- 16/03/12 | PubMed.gov
- 16/03/12 | Daily Mail
- 16/03/12 | BBC News
- 16/03/12 | Sunday Mercury
- 16/03/12 | Digital Journal
- 16/03/12 | US News
- 16/03/12 | Medical Daily
- 16/03/12 | SouthCoastTODAY.com
- 16/03/12 | National Catholic Register
- 16/03/12 | Huffington Post
- 16/03/12 | The Independent
- 16/03/12 | Daily Mail
- 16/03/12 | BBC News
- 16/03/12 | StemCellResearchNews.com
- 16/03/12 | SpringerLink
- 16/03/12 | 7th Space Interactive
- 16/03/12 | Investor Stem Cell
- 16/03/12 | Cord Blood
- 16/03/12 | health24
- 16/03/12 | Wiley Online Library
- 16/03/12 | MiD DAY
- 16/03/12 | Marketwire
- 16/03/12 | Times Online (New Zealand)
- 16/03/12
- 16/03/12 | HealthNewsDigest
- 16/03/12 | BioNews
- 16/03/12 | The Examiner
- 16/03/12 | National Public Radio
- 16/03/12 | Fox News
- 16/03/12 | PRWeb
- 16/03/12 | Uppsala Universitet
- 16/03/12 | newswise
- 16/03/12 | Reuters
- 16/03/12 | MNT
- 16/03/12 | Metro
- 16/03/12 | The Telegraph
- 16/03/12 | Daily Express
- 16/03/12 | The Star
- 16/03/12 | Cell Transplantation Center of Excellence for Aging and Brain Repair
- 16/03/12 | Fox News
- 16/03/12
- 16/03/12
- 16/03/12
- 16/03/12
- 16/03/12
- 16/03/12
- 16/03/12
- 16/03/12
- 16/03/12
- 16/03/12
- 16/03/12
- 16/03/12
- 16/03/12 | Medical News Today
- 16/03/12
-
Osiris Therapeutics Receives FDA Orphan Drug Designation For Stem Cell Treatment For Type 1 Diabetes16/03/12
- 16/03/12








